1551 - 1575 of 7665 Results
Title
Year
-
RESTRICTEDTitle: Quality of Life for Patients With Parkinson DiseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 98Issue #: 22Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000200741Best OA location URL: https://n.neurology.org/content/neurology/98/22/e2293.full.pdfCitation Count: 2
-
RESTRICTEDTitle: Fist-Palm Test (FiPaT): a bedside motor tool to screen for global cognitive statusJournal Name: Neurological SciencesPublisher: Springer Science and Business Media LLCVol: 43Issue #: 9Start Page: 5251End Page: 5258Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1007/s10072-022-06129-1Best OA location URL: https://link.springer.com/content/pdf/10.1007/s10072-022-06129-1.pdfCitation Count: 0
-
RESTRICTEDTitle: Heart-brain synchronization breakdown in Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00323-wBest OA location URL: https://www.nature.com/articles/s41531-022-00323-w.pdfCitation Count: 2
-
RESTRICTEDTitle: Immune Senescence, Immunosenescence and AgingJournal Name: Frontiers in AgingPublisher: Frontiers Media SAVol: 3Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.3389/fragi.2022.900028Best OA location URL: https://www.frontiersin.org/articles/10.3389/fragi.2022.900028/pdfCitation Count: 59
- Inhibition of autophagic flux by S-nitrosylation of SQSTM1/p62 promotes neuronal secretion and cell-to-cell transmission of SNCA/α-synuclein in Parkinson disease and Lewy body dementia2022RESTRICTEDTitle: Inhibition of autophagic flux by S-nitrosylation of SQSTM1/p62 promotes neuronal secretion and cell-to-cell transmission of SNCA/α-synuclein in Parkinson disease and Lewy body dementiaJournal Name: Autophagy ReportsPublisher: Informa UK LimitedVol: 1Issue #: 1Start Page: 223End Page: 225Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1080/27694127.2022.2076770Best OA location URL: https://www.tandfonline.com/doi/pdf/10.1080/27694127.2022.2076770?needAccess=trueCitation Count: 2
- Caregiving concerns and clinical characteristics across neurodegenerative and cerebrovascular disorders in the Ontario neurodegenerative disease research initiative2022RESTRICTEDTitle: Caregiving concerns and clinical characteristics across neurodegenerative and cerebrovascular disorders in the Ontario neurodegenerative disease research initiativeJournal Name: International Journal of Geriatric PsychiatryPublisher: WileyVol: 37Issue #: 6Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/gps.5727Best OA location URL: https://psyarxiv.com/rxqev/downloadCitation Count: 3
- Electrocorticography is superior to subthalamic local field potentials for movement decoding in Parkinson’s disease2022RESTRICTEDTitle: Electrocorticography is superior to subthalamic local field potentials for movement decoding in Parkinson’s diseaseJournal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 11Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.7554/elife.75126Best OA location URL: https://doi.org/10.7554/elife.75126Citation Count: 34
-
OPENTitle: Elucidating the importance and regulation of key enhancers for human MEIS1 expressionJournal Name: LeukemiaPublisher: Springer Science and Business Media LLCVol: 36Issue #: 8Start Page: 1980End Page: 1989Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41375-022-01602-4Best OA location URL: https://www.nature.com/articles/s41375-022-01602-4.pdfCitation Count: 3
-
RESTRICTEDTitle: Genome-wide analysis furthers decoding of Alzheimer disease geneticsJournal Name: Nature Reviews NeurologyPublisher: Springer Science and Business Media LLCVol: 18Issue #: 7Start Page: 387End Page: 388Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/s41582-022-00678-xCitation Count: 7
-
RESTRICTEDTitle: Corticobasal Syndrome with TAR Binding Protein 43–Positive Oligodendrocyte InclusionsJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 7Start Page: 1564End Page: 1565Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.29070Citation Count: 0
- Explainable machine learning with pairwise interactions for the classification of Parkinson’s disease and SWEDD from clinical and imaging features2022RESTRICTEDTitle: Explainable machine learning with pairwise interactions for the classification of Parkinson’s disease and SWEDD from clinical and imaging featuresJournal Name: Brain Imaging and BehaviorPublisher: Springer Science and Business Media LLCVol: 16Issue #: 5Start Page: 2188End Page: 2198Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s11682-022-00688-9Best OA location URL: https://link.springer.com/content/pdf/10.1007/s11682-022-00688-9.pdfCitation Count: 13
-
RESTRICTEDTitle: Intracellular Aβ42 Aggregation Leads to Cellular ThermogenesisJournal Name: Journal of the American Chemical SocietyPublisher: American Chemical Society (ACS)Vol: 144Issue #: 22Start Page: 10034End Page: 10041Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1021/jacs.2c03599Best OA location URL: https://www.repository.cam.ac.uk/bitstreams/2ebb814e-3b56-4c26-8129-80dd0e93e171/downloadCitation Count: 17
- The Role of Alpha-Synuclein Autoantibodies in the Induction of Brain Inflammation and Neurodegeneration in Aged Humans2022RESTRICTEDTitle: The Role of Alpha-Synuclein Autoantibodies in the Induction of Brain Inflammation and Neurodegeneration in Aged HumansJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2022.902191Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2022.902191/pdfCitation Count: 3
-
RESTRICTEDTitle: Dynamics of Nigral Iron Accumulation in Parkinson's Disease: From Diagnosis to Late StageJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 8Start Page: 1654End Page: 1662Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.29062Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9810258Citation Count: 20
- Library-Derived Peptide Aggregation Modulators of Parkinson’s Disease Early-Onset α-Synuclein Variants2022RESTRICTEDTitle: Library-Derived Peptide Aggregation Modulators of Parkinson’s Disease Early-Onset α-Synuclein VariantsJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 13Issue #: 12Start Page: 1790End Page: 1804Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1021/acschemneuro.2c00190Best OA location URL: https://pubs.acs.org/doi/pdf/10.1021/acschemneuro.2c00190Citation Count: 3
- The GBA1 D409V mutation exacerbates synuclein pathology to differing extents in two alpha-synuclein models2022RESTRICTEDTitle: The GBA1 D409V mutation exacerbates synuclein pathology to differing extents in two alpha-synuclein modelsJournal Name: Disease Models & MechanismsPublisher: The Company of BiologistsVol: 15Issue #: 6Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1242/dmm.049192Best OA location URL: https://journals.biologists.com/dmm/article-pdf/15/6/dmm049192/2145803/dmm049192.pdfCitation Count: 3
-
RESTRICTEDTitle: The Role of Ubiquitin in Regulating Stress Granule DynamicsJournal Name: Frontiers in PhysiologyPublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fphys.2022.910759Best OA location URL: https://www.frontiersin.org/articles/10.3389/fphys.2022.910759/pdfCitation Count: 12
- Appropriateness of Applying Cerebrospinal Fluid Biomarker Cutoffs from Alzheimer’s Disease to Parkinson’s Disease2022RESTRICTEDTitle: Appropriateness of Applying Cerebrospinal Fluid Biomarker Cutoffs from Alzheimer’s Disease to Parkinson’s DiseaseJournal Name: Journal of Parkinson's DiseasePublisher: IOS PressVol: 12Issue #: 4Start Page: 1155End Page: 1167Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.3233/jpd-212989Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9934950Citation Count: 9
-
RESTRICTEDTitle: Automatic Facial Asymmetry Analysis for Elderly Stroke Detection by using Cosine SimilarityJournal Name: 2022 19th International Conference on Electrical Engineering/Electronics, Computer, Telecommunications and Information Technology (ECTI-CON)Publisher: IEEEVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1109/ecti-con54298.2022.9795508Citation Count: 1
- Beta2-adrenoreceptor agonist clenbuterol produces transient decreases in alpha-synuclein mRNA but no long-term reduction in protein2022RESTRICTEDTitle: Beta2-adrenoreceptor agonist clenbuterol produces transient decreases in alpha-synuclein mRNA but no long-term reduction in proteinJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00322-xBest OA location URL: https://www.nature.com/articles/s41531-022-00322-x.pdfCitation Count: 6
- Brain atrophy pattern in de novo Parkinson’s disease with probable RBD associated with cognitive impairment2022RESTRICTEDTitle: Brain atrophy pattern in de novo Parkinson’s disease with probable RBD associated with cognitive impairmentJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00326-7Best OA location URL: https://www.nature.com/articles/s41531-022-00326-7.pdfCitation Count: 9
- Evaluation of the Impact of Integrated Care and Self-Management After Deep Brain Stimulation in Parkinson’s Disease2022RESTRICTEDTitle: Evaluation of the Impact of Integrated Care and Self-Management After Deep Brain Stimulation in Parkinson’s DiseaseJournal Name: Journal of Parkinson's DiseasePublisher: IOS PressVol: 12Issue #: 4Start Page: 1279End Page: 1284Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.3233/jpd-212911Citation Count: 1
- Including People with Parkinson’s Disease in Clinical Study Design and Execution: A Call to Action2022RESTRICTEDTitle: Including People with Parkinson’s Disease in Clinical Study Design and Execution: A Call to ActionJournal Name: Journal of Parkinson's DiseasePublisher: IOS PressVol: 12Issue #: 4Start Page: 1359End Page: 1363Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-223190Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd223190?id=journal-of-parkinsons-disease%2Fjpd223190Citation Count: 10
- Intercountry comparisons of advanced Parkinson's disease symptoms and management: Analysis from the OBSERVE‐PD observational study2022RESTRICTEDTitle: Intercountry comparisons of advanced Parkinson's disease symptoms and management: Analysis from the OBSERVE‐PD observational studyJournal Name: Acta Neurologica ScandinavicaPublisher: Hindawi LimitedVol: 146Issue #: 2Start Page: 167End Page: 176Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.1111/ane.13648Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ane.13648Citation Count: 3
-
RESTRICTEDTitle: Parkinson’s Disease Drug Therapies in the Clinical Trial Pipeline: 2022 UpdateJournal Name: Journal of Parkinson's DiseasePublisher: IOS PressVol: 12Issue #: 4Start Page: 1073End Page: 1082Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-229002Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd229002?id=journal-of-parkinsons-disease%2Fjpd229002Citation Count: 56